Rubric Capital Management (New York)’s Pediatrix Medical MD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-3,133,299
Closed -$45.4M 69
2025
Q1
$45.4M Sell
3,133,299
-15,141
-0.5% -$215K 0.81% 32
2024
Q4
$41.3M Sell
3,148,440
-5,126,560
-62% -$70.8M 0.53% 37
2024
Q3
$95.9M Buy
8,275,000
+125,000
+2% +$1.18M 1.56% 12
2024
Q2
$61.5M Buy
8,150,000
+7,241,400
+797% +$59.9M 1.61% 25
2024
Q1
$9.11M Buy
+908,600
New +$8.45M 0.27% 57
2020
Q4
Sell
-560,857
Closed -$9.13M 75
2020
Q3
$9.13M Buy
+560,857
New +$10.4M 0.85% 41

Other funds holding MD

Rubric Capital Management (New York)'s MD Position: Q2 2025 in Review

Rubric Capital Management (New York) sold out of Pediatrix Medical (MD) in Q2 2025, closing a stake of 3,133,299 shares — an estimated $45.4M sold.

Rubric Capital Management (New York) first reported a position in MD in Q3 2020 and held it in 6 quarters. The position peaked at $95.9M in Q3 2024. 264 funds tracked by Wall St. Rank hold MD as of Q2 2025.

  • Rubric Capital Management (New York) reported no remaining Pediatrix Medical position as of Q2 2025 after selling out during the quarter.
  • Rubric Capital Management (New York) sold 3,133,299 Pediatrix Medical shares in Q2 2025, an estimated $45.4M.
  • Rubric Capital Management (New York) first reported a position in Pediatrix Medical in Q3 2020 and held it in 6 quarters.
  • Rubric Capital Management (New York)'s Pediatrix Medical position peaked at $95.9M in Q3 2024.
  • 264 funds tracked by Wall St. Rank held Pediatrix Medical as of Q2 2025.

Based on Rubric Capital Management (New York)'s 13F filing for Q2 2025, filed 14 Aug 2025.